For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Centaur Pharmaceuticals, Inc.

USPTO Granted Patents = 35

% Expired Patents = 2.9

Forward Citations = 147

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Allan L Wilcox (23 out of 34 patents)

William D Flitter (18 out of 20 patents)

William A Garland (17 out of 19 patents)

4. Yong-Kang Zhang (12 out of 60 patents)

5. Kirk R Maples (12 out of 37 patents)

6. Richard E Paylor (12 out of 14 patents)

7. Judith A Kelleher (11 out of 11 patents)

8. Ian Irwin (6 out of 10 patents)

9. Beverly Greenwood Van-Meerveld (5 out of 5 patents)

10. John M Carney (4 out of 21 patents)

11. Lowell David Waterbury (4 out of 4 patents)

12. Julian Levell (3 out of 3 patents)

13. Alina Dykman (3 out of 3 patents)

14. Hong Xu (3 out of 3 patents)

15. Kenneth W Narducy (3 out of 3 patents)

Core Competencies:

Aryl Nitrone

Neurodegenerative Disorders

Inflammatory Bowel Disease

Pharmaceutical Compositions

Benzamide

Furan Compounds

Thioether

Acetamidobenzamide

Therapeutics

Autoimmune Disease

Angiogenesis

35 patents: Sort by Forward Citations

1. 6545056 - Aryl nitrone therapeutics and methods for treating inflammatory bowel disease (2003-04-08),

2. 6509378 - Acetamidobenzamide compounds for neurodegenerative disorders (2003-01-21),

3. 6486349 - Amide therapeutics and methods for treating inflammatory bowel disease (2002-11-26),

4. 6441032 - Alpha-(4-Ethoxyphenyl)-N-tert-butylnitrone, pharmaceutical compositions and their medical use (2002-08-27),

5. 6433008 - &agr;-aryl-N-alkylnitrones and pharmaceutical compositions containing the same (2002-08-13),

6. 6376540 - Furan nitrone compounds (2002-04-23),

7. 6342523 - 3,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation (2002-01-29),

8. 6310092 - Methods for preventing and treating autoimmune and inflammatory disease using thioether furan nitrone compounds (2001-10-30),

9. 6271265 - Amide therapeutics for the treatment of inflammatory bowel disease (2001-08-07),

10. 6258852 - Aryl nitrone therapeutics for the treatment of inflammatory bowel disease (2001-07-10),

11. 6255353 - Inhibition of angiogenesis (2001-07-03),

12. 6197826 - &agr;-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation (2001-03-06),

13. 6194465 - Benzamide therapeutics for the treatment of inflammatory bowel disease (2001-02-27),

14. 6140369 - Benzamides for neurodegenerative disorder treatment (2000-10-31),

15. 6140356 - Opthalmic pharmaceutical compositions comprising a nitrone compound and (2000-10-31),

Company Overview

Centaur Pharmaceuticals, Inc. is a biotechnology company based in Sunnyvale, California, specializing in the development and manufacturing of innovative pharmaceutical products. The company focuses on advancing therapeutic solutions across various medical domains, including oncology and neurology. With a commitment to research and development, Centaur Pharmaceuticals aims to address unmet medical needs through cutting-edge technologies and collaborative partnerships, contributing to the evolution of healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

35 Patents

#127 in Sunnyvale, CA

#2,311 in California

#9,756 in US

#19,181 in the World

Sunnyvale, CA, United States of America

Centaur Pharmaceuticals, Inc.

Forward Citations = 147

20 inventors:

Allan L Wilcox (23 out of 34 patents)

William D Flitter (18 out of 20 patents)

William A Garland (17 out of 19 patents)

4. Yong-Kang Zhang (12 out of 60 patents)

5. Kirk R Maples (12 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Centaur Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/centaur-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…